Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$22.9K Buy
102
+23
+29% +$5.73K ﹤0.01% 1488
2025
Q4
$19K Buy
79
+78
+7,800% +$19.9K ﹤0.01% 1577
2025
Q3
$274 Hold
1
﹤0.01% 1880
2025
Q2
$258 Hold
1
﹤0.01% 1883
2025
Q1
$224 Hold
1
﹤0.01% 1695
2024
Q4
$229 Hold
1
﹤0.01% 1725
2024
Q3
$244 Buy
+1
New +$223 ﹤0.01% 1684
2023
Q1
Sell
-2
Closed 2040
2022
Q4
$0 Buy
+2
New +$439 ﹤0.01% 1923

Other funds holding RMD

Ancora Advisors's RMD Position: Q1 2026 in Review

Ancora Advisors increased its ResMed (RMD) stake by 29% in Q1 2026, buying an estimated $5.73K and bringing the position to 102 shares worth $22.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1488.

Ancora Advisors first reported a position in RMD in Q4 2022 and has held it in 8 quarters since. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Ancora Advisors held 102 shares of ResMed worth $22.9K as of Q1 2026.
  • Ancora Advisors bought 23 ResMed shares in Q1 2026, an estimated $5.73K.
  • ResMed made up ﹤0.01% of Ancora Advisors's portfolio in Q1 2026, its #1488 holding.
  • Ancora Advisors first reported a position in ResMed in Q4 2022 and has held it in 8 quarters since.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Ancora Advisors's 13F filing for Q1 2026, filed 15 May 2026.